A carregar...

Management of specialty drugs, specialty pharmacies and biosimilars in the United States

Background: Specialty medicines continue to increase as a percentage of spending with biologics representing a large portion of specialty spending. Health plans expect to adjust their formularies to maximize expected savings from biosimilars. Objectives: A better understanding of health plan managem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Drug Assess
Main Authors: Brook, Richard A., Sax, Michael J., Carlisle, Jeffrey A., Smeeding, Jim E.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764408/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658331
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!